Creative medical technology holdings engages highly respected international cro for phase 1 / 2 clinical trial to treat type 1 diabetes using celz-201

Phoenix--(business wire)--creative medical technology holdings, inc.
CELZ Ratings Summary
CELZ Quant Ranking